Seeking Alpha

TKMR
  Tekmira Pharmaceuticals Corp - NASDAQ

9/17/2014, 11:33 AM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
TKMR vs. ETF Alternatives
Company Description
Tekmira Pharmaceuticals Corp develops ribonucleic acid interference therapeutic product candidates as well as provides its lipid nanoparticle delivery technology to pharmaceutical partners in the Canada.